MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Medicenna Therapeutics Corp.
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Mar 31, 2023
Medicenna Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Medicenna Therapeutics's annual report. Trading prices and yields need FINRA TRACE data.